122 related articles for article (PubMed ID: 38104284)
61. Characterization of the first microRNA in human CDH1 that affects cell cycle and apoptosis and indicates breast cancers progression.
Gharbi S; Mohammadi Z; Dezaki MS; Dokanehiifard S; Dabiri S; Korsching E
J Cell Biochem; 2022 Mar; 123(3):657-672. PubMed ID: 34997630
[TBL] [Abstract][Full Text] [Related]
62. Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.
Kuusisto KM; Bebel A; Vihinen M; Schleutker J; Sallinen SL
Breast Cancer Res; 2011 Feb; 13(1):R20. PubMed ID: 21356067
[TBL] [Abstract][Full Text] [Related]
63. Decreased fragile histidine triad gene messenger RNA expression in lung cancer.
Sasaki H; Haneda H; Yukiue H; Kobayashi Y; Yano M; Fujii Y
Clin Lung Cancer; 2006 May; 7(6):412-6. PubMed ID: 16800968
[TBL] [Abstract][Full Text] [Related]
64. Promoter hypermethylation of CDH1, FHIT, MTAP and PLAGL1 in gastric adenocarcinoma in individuals from Northern Brazil.
Leal M; Lima E; Silva P; Assumpção P; Calcagno D; Payão S; Burbano RR; Smith M
World J Gastroenterol; 2007 May; 13(18):2568-74. PubMed ID: 17552003
[TBL] [Abstract][Full Text] [Related]
65. Identification of an intronic single nucleotide polymorphism leading to allele dropout during validation of a CDH1 sequencing assay: implications for designing polymerase chain reaction-based assays.
Mullins FM; Dietz L; Lay M; Zehnder JL; Ford J; Chun N; Schrijver I
Genet Med; 2007 Nov; 9(11):752-60. PubMed ID: 18007144
[TBL] [Abstract][Full Text] [Related]
66. [Study on the association between IL-2R and IL-7R gene polymorphism and idiopathic demyelinating optic neuritis].
Zhao YY; Wei SH; Dai P; Yuan HJ
Zhonghua Yan Ke Za Zhi; 2010 Dec; 46(12):1066-70. PubMed ID: 21211217
[TBL] [Abstract][Full Text] [Related]
67. Abnormal FHIT gene transcript and c-myc and c-erbB2 amplification in breast cancer.
Kowara R; Gołebiowski F; Chrzan P; Skokowski J; Karmolinski A; Pawełczyk T
Acta Biochim Pol; 2002; 49(2):341-50. PubMed ID: 12362975
[TBL] [Abstract][Full Text] [Related]
68. Association between CDH1 haplotypes and gastric cancer risk in a Japanese population.
Yamada H; Shinmura K; Ikeda S; Tao H; Otani T; Hanaoka T; Tsuneyoshi T; Tsugane S; Sugimura H
Scand J Gastroenterol; 2007 Dec; 42(12):1479-85. PubMed ID: 17852867
[TBL] [Abstract][Full Text] [Related]
69. Single nucleotide polymorphisms in the promoter region of the E-cadherin gene in gastric cancer: case-control study in a young Mexican population.
Medina-Franco H; Ramos-De la Medina A; Vizcaino G; Medina-Franco JL
Ann Surg Oncol; 2007 Aug; 14(8):2246-9. PubMed ID: 17549573
[TBL] [Abstract][Full Text] [Related]
70. Association between the CDH1-472delA and -160C>A polymorphisms and diffuse and intestinal gastric cancer in a Mexican population.
Bustos-Carpinteyro AR; Delgado-Figueroa N; Santiago-Luna E; Magaña-Torres MT; Sánchez-López JY
Genet Mol Res; 2016 Sep; 15(3):. PubMed ID: 27706737
[TBL] [Abstract][Full Text] [Related]
71. Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: relationships with abnormal E-cadherin and catenin expression and microsatellite instability.
Sarrió D; Moreno-Bueno G; Hardisson D; Sánchez-Estévez C; Guo M; Herman JG; Gamallo C; Esteller M; Palacios J
Int J Cancer; 2003 Aug; 106(2):208-15. PubMed ID: 12800196
[TBL] [Abstract][Full Text] [Related]
72. Analysis of E-cadherin (CDH1) Gene Polymorphism and Its Association with Cervical Cancer Risk in Bangladeshi Women.
Rahman MA; Hasan MM; Hossain A; Alam KM; Sultana R; Mazid MA; Rahman MM
Asian Pac J Cancer Prev; 2023 Jul; 24(7):2361-2368. PubMed ID: 37505767
[TBL] [Abstract][Full Text] [Related]
73. CYP17 (T-34C) and CYP19 (Trp39Arg) polymorphisms and their cooperative effects on breast cancer susceptibility.
Tüzüner BM; Oztürk T; Kisakesen HI; Ilvan S; Zerrin C; Oztürk O; Isbir T
In Vivo; 2010; 24(1):71-4. PubMed ID: 20133979
[TBL] [Abstract][Full Text] [Related]
74. The Potential Role of CDH1 as an Oncogene Combined With Related miRNAs and Their Diagnostic Value in Breast Cancer.
Xie D; Chen Y; Wan X; Li J; Pei Q; Luo Y; Liu J; Ye T
Front Endocrinol (Lausanne); 2022; 13():916469. PubMed ID: 35784532
[TBL] [Abstract][Full Text] [Related]
75. Candidate gene association analysis of multiple sclerosis in the Jordanian Arab population: A case-control study.
Al-Eitan L; Al Qudah M; Al Qawasmeh M
Gene; 2020 Oct; 758():144959. PubMed ID: 32683075
[TBL] [Abstract][Full Text] [Related]
76. Analysis of the FHIT gene and FRA3B region in sporadic breast cancer, preneoplastic lesions, and familial breast cancer probands.
Ahmadian M; Wistuba II; Fong KM; Behrens C; Kodagoda DR; Saboorian MH; Shay J; Tomlinson GE; Blum J; Minna JD; Gazdar AF
Cancer Res; 1997 Sep; 57(17):3664-8. PubMed ID: 9288768
[TBL] [Abstract][Full Text] [Related]
77. Long non‑coding RNA LINC00312 regulates breast cancer progression through the miR‑9/CDH1 axis.
Chen Y; Qiu F; Huang L; Liu W; Li L; Ji C; Zeng X; Qiao L; Liu M; Gong X
Mol Med Rep; 2020 Mar; 21(3):1296-1303. PubMed ID: 31894332
[TBL] [Abstract][Full Text] [Related]
78. [Promoter methylation profile in breast cancer].
Roa JC; Anabalón L; Tapia O; Martínez J; Araya JC; Villaseca M; Guzmán P; Roa I
Rev Med Chil; 2004 Sep; 132(9):1069-77. PubMed ID: 15543763
[TBL] [Abstract][Full Text] [Related]
79. Clinical features and cancer risk in families with pathogenic
Xicola RM; Li S; Rodriguez N; Reinecke P; Karam R; Speare V; Black MH; LaDuca H; Llor X
J Med Genet; 2019 Dec; 56(12):838-843. PubMed ID: 31296550
[TBL] [Abstract][Full Text] [Related]
80. Interleukin 7 receptor alpha polymorphism rs6897932 and susceptibility to multiple sclerosis in the Western Balkans.
Stanković A; Dincić E; Ristić S; Lovrecić L; Starcević Cizmarević N; Djurić T; Sepcić J; Kapović M; Raicević R; Peterlin B; Alavantić D; Zivković M
Mult Scler; 2010 May; 16(5):533-6. PubMed ID: 20194581
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
